Two years ago, Eli Lilly started working with Dexcom to integrate continuous glucose monitoring (CGM) into its insulin delivery devices, and it has now firmed up the alliance. Lilly has taken a ...
Connacht host URC leaders Glasgow Warriors on Saturday afternoon.
Dr. Ahn shares how diabetology fellowships can help health systems expand specialty diabetes care amid rising demand.
Q4 2025 Earnings Call February 12, 2026 4:30 PM ESTCompany ParticipantsSean Christensen - Vice President of Finance and ...
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. DexCom reported strong preliminary Q4 results, with topline figures above its ...
Farrell placed improving discipline at the top of his list of improvements and also addressed the penalty Aki conceded for dissent at the Dexcom last Saturday, agreeing work still needed to be done wi ...
The daily tab highlights a user’s current and recent glucose readings, their time in range, logged events and insights. Insights are displayed at the top of the daily tab. The nutrition section gives ...
Weeks after launching its first open call for diabetes advocates, Dexcom is spotlighting the resulting group of 16 people in a new awareness campaign. The project kicked off Friday, World Diabetes Day ...
DexCom (DXCM) stock ought to be included on your watchlist. Here is why – it is presently trading within the support range ($55.31 – $61.13), levels from which it has bounced significantly in the past ...
Oct 30 (Reuters) - Medical device maker Dexcom (DXCM.O), opens new tab topped Wall Street estimates for third-quarter results on Thursday, driven by robust demand for its continuous glucose monitoring ...
DexCom Inc. (DXCM) reported its third-quarter earnings for 2025, surpassing analysts’ expectations with an EPS of $0.61 compared to a forecasted $0.57, marking a 7.02% earnings surprise. Revenue also ...
A recent investigation by Hunterbrook alleged that Dexcom "dropped the ball" in ensuring the accuracy and reliability of its G7 glucose monitoring device. Some patients reportedly experienced severe ...